We're cutting our price target on Danaher as frustration mounts after a messy quarter
Shares tumbled more than 8% after in response to fourth-quarter earnings and 2025 guidance.
Tekef
0
51
A worker uses a machine made by Pall Corp. during a demonstration of the clarification stage of the production of influenza vaccine during a tour at a Sanofi Pasteur vaccine production facility in Swiftwater, Pennsylvania.
Stephen Hilger | Bloomberg | Getty Images
Danaher shares are under pressure Wednesday as the Club holding's fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience.
+Japan+x+Black+Rock+Press+Release_30+July+2024.jpg&h=630&w=1200&q=100&v=5f99a4b43f&c=1)
